Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and BKM120 in Endocrine Resistant ER+/HER2- Breast Cancer
NCT01953445Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of buparlisib in breast cancer, sponsored by Washington University School of Medicine. Planned start Aug 2014; status: withdrawn.
02
Drugs
buparlisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01953445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01953445.